￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Is Vidicitomab (Aidexi) an immune drug or a targeted drug and its mechanism of action?

2026-02-01 22:25:32

Check Details
Analysis of whether isatuximab (Xalcoyi) requires long-term medication and its safety

2026-02-01 22:25:32

Check Details
Analysis of applicable gene mutation types, efficacy and patient population of capivasertib

2026-02-01 22:25:32

Check Details
Comparison of efficacy and indications between guselkumab (Tenoya) and secukinumab

2026-02-01 22:25:32

Check Details
Tenapanor production country and manufacturer information and clinical use channel instructions

2026-02-01 22:25:32

Check Details
None

2026-02-01 22:25:32

Check Details
Differences, indications and medication comparison between Guanfacine and Clonidine

2026-02-01 22:25:32

Check Details
The price of Dabrafenib has "transformed" from tens of thousands of yuan to several thousand yuan. How can it benefit patients with BRAF mutations?

2026-02-01 22:25:32

Check Details
Current status and progress of the launch of Quizartinib in China

2026-02-01 22:25:32

Check Details
Pomalidomide plus taskatumumab maintains deep, durable responses in R/R multiple myeloma

2026-02-01 22:25:32

Check Details
How long does it take for Lapatinib/Talisat to be effective and what is the course of treatment?

2026-02-01 22:25:32

Check Details
Can I not stop taking filgotinib once I start taking it?

2026-02-01 22:25:32

Check Details
Category
相关知识